The science of microRNAs continues to generate new insights into cancer and disease treatment. New research shows that four specific miRNAs will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians.